MATTHEW TRAUTMAN: Open Payments
NPI 1972073260 · BEND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,280 in 147 payments from 16 companies in 2025. Trend: 2023 $1,481 · 2024 $2,630 · 2025 $2,280
Food & beverage: $2,280
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 59 | $570 |
| Lilly USA, LLC | 15 | $321 |
| GENZYME CORPORATION | 14 | $287 |
| Janssen Biotech, Inc. | 23 | $213 |
| UCB, Inc. | 9 | $202 |
| Organon LLC | 3 | $199 |
| Galderma Laboratories, L.P. | 8 | $156 |
| LEO Pharma Inc. | 4 | $91 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| Arcutis Biotherapeutics, Inc. | 3 | $45 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, RINVOQ, Bimzelx, TALTZ, VTAMA, NEMLUVIO.
Industry payments across OR — which companies pay providers there.
